Rapid Response Regulatory Mechanism for COVID-19
The Department of Biotechnology (DBT) took several steps to streamline the biosafety regulation and provide facilities to researchers and industries which have been undertaking research and development in Recombinant DNA (rDNA)Technology and Hazardous Microorganisms.
Related News >> COVID-19 cases are over 50k in Bengaluru Urban
- In Jan 2020, The Department released the updated Guidelines. according to new Guidelines, the Institutional Biosafety Committee was delegated authority that can take decisions on applications of import-export and exchange of GE organisms and products thereof for R&D purposes for RG1 and RG2 items.
About Department of Biotechnology (DBT) –
Secretary: Renu Swarup
Headquarters: New Delhi